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ABSTRACT
Objective: The aim of this research is to prepare and characterize cocrystals of acyclovir through cocrystallization of acyclovir-succinic acid (AS) to 
improve the physical properties of the drug.
Methods: AS cocrystals were prepared using solvent evaporation method. The cocrystals were characterized by polarization microscope, scanning 
electron microscopy (SEM), differential scanning calorimetry, powder X-ray diffraction (PXRD), and Fourier transform infrared spectroscopy.
Results: Physical characterization using polarization microscope and SEM showed the AS cocrystals have unique crystal habit and morphology. Phase 
diagram at a molar ratio of 50:50% (acyclovir:succinic acid) showed a decrease in the melting temperature, i.e., 176.23°C in comparison with the 
melting point of the constituent materials (acyclovir 253.53°C and succinic acid 187.29°C). The PXRD pattern of AS cocrystals (ethanol) exhibited 
new diffraction peaks at 2θ=5.91°; 9.16°; and 13.40°. Besides, cocrystals of AS (glacial acetic acid) indicated new peaks at 2θ=5.98°; 9.19°; and 13.43°. 
Furthermore, there was a shift in the N-H, O-H, and C=O.
Conclusion: Cocrystallization of AS acid in ethanol and glacial acetic acid were successfully formed using solvent evaporation methods.
Keywords: Acyclovir-succinic acid, Cocrystal, Characterization, Solvent evaporation method.
INTRODUCTION
The properties of the pharmaceutical solid such as solubility and 
dissolution rate are important as the ability to manufacture the solid 
dosage form at scale. Attempting to find a solid with the desired 
properties and manufacturability, companies spend significant 
effort looking for polymorphs, salts, and cocrystal of their active 
pharmaceutical ingredients (API’s) [1-5].
Cocrystal is a homogenous crystalline material composed of a neutral 
target and a neutral coformer held together through noncovalent bonds. 
For pharmaceutical applications, it is essential that the coformers have 
generally recognized as safe status. The physicochemical properties of 
API’s can be modified while the intrinsic activities of these drug molecules 
remain the same. From the thermodynamic point of view, pharmaceutical 
cocrystals are stable and high energy forms. Therefore, they can have 
impact on solubility and dissolution rate of the drug. The strategy 
involves drug-coformer combinations that have the potential of forming 
energetically and structurally robust interactions [3-8]. Pharmaceutical 
cocrystals often rely on hydrogen-bonded assemblies between an API 
and coformer with well-defined stoichiometries. For a target API, we are 
interested in coformers with functional groups that can interact (i.e., form 
H-bonds) with the functional groups on the API. Common functional 
groups - such as carboxylic acids, amides, and alcohols - are typically 
found to interact with one another in cocrystals [3,9,10].
Acyclovir, a guanosine analog antiviral drug with a solubility of 
1.62 mg/mL. Due to its poor solubility and permeability, the bioavailability 
of acyclovir attains just 15-30% [11-14]. Carboxylic acids are considered 
as coformers to form cocrystals with acyclovir. A group of carboxylic 
acids including succinic acid, glutaric acid, and adipic acid [13].
Solvent evaporation is the most conventional technique of 
cocrystallization which includes super saturation of solution by 
evaporation, cooling and addition of solubility changing solvent or 
substance [15].
The aim of this research was to prepare and characterize cocrystals of 
acyclovir through cocrystallization of acyclovir-succinic (AS) acid to 
improve the physical properties of the drug. The obtained of cocrystals 
were characterized by microscope polarization, scanning electron 
microscopy (SEM), differential scanning calorimetry (DSC), powder 




Acyclovir commercial material was obtained from Sigma (USA). 
Succinic acid, ethanol, and glacial acetic acid were purchased from 
Merck Chemicals (Germany) without any purification.
Methods
Phase diagram preparation of AS acid
AS acid was sifted and weighed to obtain a similar range of particle 
size. Both of samples were mixing at different molar ratios, i.e., 
(10/90), (20/80), (30/70), (40/60), (50/50), (60/40), (70/30), 
(80/20), and (90/10) to obtain the AS physical mixture. The mixture 
was gently mixed in a mortar for 5 minutes. Examination of melting 
point of AS physical mixture was determined by DSC. Phase diagram of 
AS describes the molar fraction of the mixture against the endothermic 
peak [16].
Preparation of AS cocrystals by solvent evaporation
AS acid carefully weighed equimolar. Each compound was dissolved in 
ethanol separately. The both of solutions were mixed and stirred for a 
few minutes. Equimolar solution of both components was evaporated 
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at room temperature for 48 hrs. The obtained cocrystal solids were 
stored in a desiccator under vacuum [17].
Characterization by polarized microscope
About 1-2 mg of physical mixture between AS acid was placed on 
object glass. A drop of ethanol was added to each physical mixture until 
dissolved and allowed to recrystallize. Recrystallization process was 
observed under a polarizing microscope. The microscopic images were 
recorded with an Olympus SC-30 digital color camera attached to the 
Olympus BX-50 polarized microscope [18].
Characterization using SEM
Sample was placed on the sample holder and coated with gold 
aluminum with a thickness of 10 nm. The sample was then observed 
at various magnification using SEM instrument (FEI Inspect S50, USA) 
with voltage was set at 20 kV and 12 mA [16].
Thermal analysis by DSC
DSC was performed using Mettler Toledo. About 4 mg of each sample 
was placed in crimped sample pan. The sample was heated from 30 to 
300°C at a heating rate of 10°C/minutes under nitrogen purged [18].
Characterization by PXRD
PXRD (Phillips X’Pert diffractometer) analysis was performed at 
room temperature. Condition of measurement was set as follows: 
Cu metal target, Kα filter, voltage of 40 kV, and 40 mA. The analysis 
was performed on the range of 2θ of 5-40°C. Sample was placed on 
the sample holder and flatted to prevent particle orientation during 
preparation [16].
Characterization by FTIR
IR spectra were recorded using Jasco 4200-type A. The dried pure 
AS acid, physical mixture, and binary system were previously ground 
and mixed thoroughly with potassium bromide. The IR spectrum 
was obtained using IR spectrophotometer in wave length range of 
400-4000/cm [17].
RESULTS AND DISCUSSION
The cocrystallization process of AS cocrystal was observed under 
polarized microscope. Polarizing light microscopy is particularly useful 
for studying the optical properties of crystals. When crossed polarized 
light (the vibration directions of the two polarizers are oriented 90°C 
from one another) passes through an anisotropic crystal, the crystal 
will show bright interference colors, as long as it is not in an extinction 
position or aligned on an optic axis [19]. As shown in Fig. 1, AS cocrystal 
has unique crystal habit.
The phase diagram of AS binary system consists of different molar ratio 
of AS acid. The result indicated that the molar ratio of 50:50% show a 
decreased melting temperature of each component. Acyclovir melted 
at 253.53°C and succinic acid melted at 187.29°C, whereas the binary 
system of AS melted at 176.23°C. Decreasing of melting temperature 
exhibited that it formed a cocrystal as shown in Fig. 2 and Table 1.
DSC is thermal analysis method to evaluate changes in thermodynamic 
properties that occur when the material supplied heat energy. Changes 
can be observed in the process of melting, recrystallization or solid phase 
transformations indicated by endothermic or exothermic peaks. Fig. 3 
showed new endothermic peak appears at 176.23°C (ΔH=1.07 Jg−1) for 
AS physical mixture; 177.45°C (ΔH=0.87 Jg−1) for AS cocrystal (ethanol) 
and 178.41°C (ΔH=0.78 Jg−1) for AS cocrystal (glacial acetic acid). The 
thermal behavior of the cocrystals was distinct with a different melting 
transition from that seen with either of the individual components; 
this suggests the formation of a new phase [11]. The changes in peak 
position may be attributed to change in powder geometry of samples 
during preparation [20].
Fig. 2: Phase diagram of acyclovir-succinic binary systems with 
various composition
Fig. 3: Differential scanning calorimetry thermogram. (A) 
Acyclovir, (B) succinic acid, (C) physical mixture acyclovir-
succinic (AS) (1:1), (D) cocrystal of AS in ethanol, (E) cocrystal of 
AS in glacial acetic acids. Arrow sign (↓) show specific diffraction 
peak in cocrystal of AS
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Table 1: Endothermic of AS acid and binary systems of AS in 
various composition
Sample Endothermic peak (°C)
T1 T2 T3
Succinic acid 187.29 - -
AS physical mixture (1:9) 155.64 181.68 -
AS physical mixture (2:8) 156.08 - -
AS physical mixture (3:7) 157.15 173.42 -
AS physical mixture (4:6) 156.65 172.27 -
AS physical mixture (5:5) 158.42 176.23 -
AS physical mixture (6:4) 157.45 172.99 -
AS physical mixture (7:3) 157.35 173.62 -
AS physical mixture (8:2) 157.40 173.75 -
AS physical mixture (9:1) 156.91 166.37 173.14
Acyclovir - 174.01 253.53
AS: Acyclovir-succinic
Fig. 4: Powder X-ray diffraction. (A) Cocrystal of acyclovir-succinic 
(AS) (acetic acid), (B) cocrystal of AS (ethanol), (C) physical 
mixture of AS (1:1), (D) succinic acid, (E) acyclovir
New crystalline phase is formed from the interaction between the two 
components will be observed clearly from the XRD. Fig. 4 showed the PXRD 
of AS cocrystals compared to the single component and physical mixture of 
both components without treatment. The PXRD pattern of AS cocrystals 
different from the pattern of a physical mixture of AS and pure component. 
The PXRD pattern of AS cocrystals showed some new interference peaks 
typical at 2θ=5.91°; 9.16°; and 13.40° (ethanol) and 2θ=5.98°; 9.19°; and 
13.43° (glacial acetic acid), which were not found in the diffractogram 
of AS acid and their physical mixture. These unique PXRD patterns of AS 
cocrystals indicate the formation of new crystalline phases [14].
Fig. 5 shows the microscopic analysis with a SEM. The powder of 
acyclovir appears in the form of particles with irregular shape and size 
(Fig. 5a). Succinic acid look like rod shape (Fig. 5b). The AS cocrystal 
(ethanol) in Fig. 5c appears like a needle shape in which the original 
morphology of both components has disappeared. Fig. 5d performed 
the AS cocrystal (glacial acetic acid) with a more homogeneous 
aggregate mixture of AS.
The IR spectrum of acyclovir two-thirds hydrate had two peaks in the 
region of 3500-3300/cm, corresponding to NH and OH, respectively, 
and the 1600/cm region was represented by a band corresponding 
to the amide group [22]. The spectrum of succinic acid had one peak 
at 3439/cm due to O-H, and the region of 1694/cm showed a band 
corresponding to C=O stretch [23]. The peaks due to N-H stretching 
acyclovir at 3440 cm−1 are now shifted to 3442/cm, similar both in 
ethanol and glacial acetic acid. The increase in the N-H stretching 
frequency in the AS cocrystals implies that amine group is 
participating in a weak hydrogen bond. In addition, the peak due to 
C=O stretching of acyclovir at 1611, 1661, and 1694/cm is shifted 
to 1612, 1664 and 1693/cm both in ethanol and glacial acetic acid. 
The peak due to C=O stretching of succinic acid at 1694/cm is now 
present as a triple peak at 1612, 1664, and 1693/cm. It is probably 
due to the stretching of the C=O employed in hydrogen bonds. 
Fig. 5: Microphotographs of (a) acyclovir, (b) succinic acid, (c) 




Fig. 6: Fourier transform infrared spectroscopy spectrum.  
(A) Acyclovir-succinic (AS) cocrystal (glacial acetic acid), (B) AS 
cocrystal (ethanol), (C) physical mixture of AS (1:1), (D) succinic 
acid, (E) acyclovir
Since every compound produces its own characteristic powder pattern 
owing to the unique crystallography of its structure, PXRD is clearly 
the most powerful and fundamental tool for a specification of the 
polymorphic identity of an analyte [21].
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A bathochromic shift in the C=O stretching frequency in succinic 
acid from 1694 to 1693/cm both in ethanol and glacial acetic acid 
further explains the formation of the AS cocrystals. Subsequently, 
the decrease in the OH stretching frequency from 3439/cm in 
succinic acid to 3442/cm both in ethanol and glacial acetic acid in 
AS cocrystals suggests that the carboxyl group is participating in a 
weak hydrogen bond (Fig. 6).
CONCLUSION
New crystalline phase is formed from the interaction between AS 
acid using solvent evaporation method. It has been characterized by 
polarized microscope, SEM, DSC, PXRD, and FTIR.
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